These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9750003)

  • 21. NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine.
    Del Arco A; Mora F
    Brain Res Bull; 2002 Mar; 57(5):623-30. PubMed ID: 11927365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the locomotor responses induced by D1-like and D2-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens.
    David HN; Sissaoui K; Abraini JH
    Neuropharmacology; 2004 Feb; 46(2):179-91. PubMed ID: 14680757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG; Gruner R; Rozental J
    Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
    Abekawa T; Ito K; Koyama T
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enflurane directly depresses glutamate AMPA and NMDA currents in mouse spinal cord motor neurons independent of actions on GABAA or glycine receptors.
    Cheng G; Kendig JJ
    Anesthesiology; 2000 Oct; 93(4):1075-84. PubMed ID: 11020764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligands of the NMDA receptor-associated glycine recognition site and motor behavior.
    Kretschmer BD
    Amino Acids; 1998; 14(1-3):227-34. PubMed ID: 9871466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
    Hiyoshi T; Kambe D; Karasawa J; Chaki S
    Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS; Breese GR
    Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
    Lamanauskas N; Nistri A
    Eur J Neurosci; 2008 May; 27(10):2501-14. PubMed ID: 18445055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
    Patel DR; Young AM; Croucher MJ
    Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in mice.
    Poleszak E; Serefko A; Szopa A; Wośko S; Dudka J; Wróbel A; Oniszczuk T; Wlaź P
    Pharmacol Rep; 2013; 65(5):1124-31. PubMed ID: 24399708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL; Wang RY
    J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons.
    Vignes M
    Neuropharmacology; 2001 May; 40(6):737-48. PubMed ID: 11369028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats.
    Wiley JL; Balster RL
    Life Sci; 2004 May; 75(2):141-51. PubMed ID: 15120567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations.
    Willmore CB; Bespalov AY; Beardsley PM
    Neurobiol Learn Mem; 2002 Sep; 78(2):347-64. PubMed ID: 12431422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW; Noraberg J; Zimmer J
    Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.
    Burns LH; Everitt BJ; Kelley AE; Robbins TW
    Psychopharmacology (Berl); 1994 Aug; 115(4):516-28. PubMed ID: 7871097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A1 receptor activation modulates N-methyl-d-aspartate (NMDA) preconditioning phenotype in the brain.
    Constantino LC; Pamplona FA; Matheus FC; Ludka FK; Gomez-Soler M; Ciruela F; Boeck CR; Prediger RD; Tasca CI
    Behav Brain Res; 2015 Apr; 282():103-10. PubMed ID: 25557798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.
    Hauber W; Waldenmeier MT
    Eur J Pharmacol; 1994 May; 256(3):339-42. PubMed ID: 7913894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.